GeneCentric Therapeutics has earned an initial $8m in a Series C funding round, marking a step towards the launch and ...

AI is being used to model gene regulation and predict cellular behavior from transcriptomic data. Learn how these tools aid ...

The clinical-stage biotech is developing gene-editing CRISPR technology. Editas has reported encouraging testing results in ...

Small RNA molecules, such as microRNAs (miRNAs) and small interfering RNAs (siRNAs), are critical regulators that orchestrate ...

Life sciences investment firm Syncona has blamed the “particularly challenging” market conditions for shifting its strategy ...

A new study reveals that transplanting healthy human glial progenitor cells into adult mice with Huntington’s disease can delay motor and cognitive decline and extend lifespan.

PepGen leverages a graph-based approach to improve the detection of hidden protein variants in a computationally efficient ...

A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile. | A second patient has ...

Huntington's disease has long defied attempts to rescue suffering neurons. A new study in Cell Reports shows that ...

To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...